These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Abnormal macrophages and NK cell cytotoxicity in human systemic lupus erythematosus and the role of interferon and serum factors. Zippel D; Lackovic V; Kocisková D; Rovenský J; Borecký L; Stelzner A Acta Virol; 1989 Sep; 33(5):447-53. PubMed ID: 2483602 [TBL] [Abstract][Full Text] [Related]
6. Inhibition of natural killer cell activity by serum from patients with systemic lupus erythematosus: roles of disease activity and serum interferon. Ytterberg SR; Schnitzer TJ Ann Rheum Dis; 1984 Jun; 43(3):457-61. PubMed ID: 6204601 [TBL] [Abstract][Full Text] [Related]
7. Natural cytotoxicity in systemic lupus erythematosus: mechanisms of suppression by inhibitory serum factors. Sibbitt WL; Froelich CJ; Bankhurst AD Clin Exp Immunol; 1983 Aug; 53(2):363-70. PubMed ID: 6883808 [TBL] [Abstract][Full Text] [Related]
8. Impaired release of a soluble natural killer cytotoxic factor in systemic lupus erythematosus. Sibbitt WL; Mathews PM; Bankhurst AD Arthritis Rheum; 1984 Oct; 27(10):1095-100. PubMed ID: 6487394 [TBL] [Abstract][Full Text] [Related]
9. Role of interleukin 2 in inducing normalization of natural killer activity in systemic lupus erythematosus. Gaspar ML; Alvarez-Mon M; Gutiérrez C Clin Immunol Immunopathol; 1988 Nov; 49(2):204-14. PubMed ID: 3139345 [TBL] [Abstract][Full Text] [Related]
10. Phenotype and function of natural killer cells in systemic lupus erythematosus: excess interferon-γ production in patients with active disease. Hervier B; Beziat V; Haroche J; Mathian A; Lebon P; Ghillani-Dalbin P; Musset L; Debré P; Amoura Z; Vieillard V Arthritis Rheum; 2011 Jun; 63(6):1698-706. PubMed ID: 21370226 [TBL] [Abstract][Full Text] [Related]
11. Natural killer cells and interferon responses in patients with systemic lupus erythematosus. Tsokos GC; Rook AH; Djeu JY; Balow JE Clin Exp Immunol; 1982 Nov; 50(2):239-45. PubMed ID: 6817954 [TBL] [Abstract][Full Text] [Related]
12. Differential expression of natural killer activating and inhibitory receptors in patients with newly diagnosed systemic lupus erythematosus. Ye Z; Ma N; Zhao L; Jiang ZY; Jiang YF Int J Rheum Dis; 2016 Jun; 19(6):613-21. PubMed ID: 24617980 [TBL] [Abstract][Full Text] [Related]
13. Phenotypic and functional analysis of natural killer cells in systemic lupus erythematosus patients. Chiang BL; Chen YC; Wang CR; Lin YL; Chou CC; Hsieh KH Zhonghua Min Guo Xiao Er Ke Yi Xue Hui Za Zhi; 1995; 36(5):357-63. PubMed ID: 8607362 [TBL] [Abstract][Full Text] [Related]
14. Abnormal natural killer cell activity in systemic lupus erythematosus: an intrinsic defect in the lytic event. Katz P; Zaytoun AM; Lee JH; Panush RS; Longley S J Immunol; 1982 Nov; 129(5):1966-71. PubMed ID: 7119439 [TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 restores the depressed allogeneic cell-mediated lympholysis and natural killer cell activity in patients with systemic lupus erythematosus. Tsokos GC; Smith PL; Christian CB; Lipnick RN; Balow JE; Djeu JY Clin Immunol Immunopathol; 1985 Mar; 34(3):379-86. PubMed ID: 3156017 [TBL] [Abstract][Full Text] [Related]
16. Natural killer cell activity in Sjögren's syndrome and systemic lupus erythematosus: stimulation with interferons and interleukin-2 and correlation with immune complexes. Struyf NJ; Snoeck HW; Bridts CH; De Clerck LS; Stevens WJ Ann Rheum Dis; 1990 Sep; 49(9):690-3. PubMed ID: 1700674 [TBL] [Abstract][Full Text] [Related]
17. Endogenous and interferon-augmented natural killer cell activity of human peripheral blood mononuclear cells in vitro. Studies of patients with multiple sclerosis, systemic lupus erythematosus or rheumatoid arthritis. Neighbour PA; Grayzel AI; Miller AE Clin Exp Immunol; 1982 Jul; 49(1):11-21. PubMed ID: 6181920 [TBL] [Abstract][Full Text] [Related]
18. Natural killer cell activity in families of patients with systemic lupus erythematosus: demonstration of a killing defect in patients. Green MR; Kennell AS; Larche MJ; Seifert MH; Isenberg DA; Salaman MR Clin Exp Immunol; 2005 Jul; 141(1):165-73. PubMed ID: 15958083 [TBL] [Abstract][Full Text] [Related]
19. Interferon and natural killer cells in systemic lupus erythematosus. Strannegård O; Hermodsson S; Westberg G Clin Exp Immunol; 1982 Nov; 50(2):246-52. PubMed ID: 6185256 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies to Killer Cell Immunoglobulin-Like Receptors in Patients With Systemic Lupus Erythematosus Induce Natural Killer Cell Hyporesponsiveness. Segerberg F; Lundtoft C; Reid S; Hjorton K; Leonard D; Nordmark G; Carlsten M; Hagberg N Front Immunol; 2019; 10():2164. PubMed ID: 31572377 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]